Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

FAQ: Carrier Testing for Cystic Fibrosis

What is cystic fibrosis? Cystic fibrosis (CF) is one of the most common life threatening genetic diseases, affecting approximately 1 out of 3,300 people. The severity of CF varies, with some children showing symptoms at birth, and others not diagnosed until th

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

What is cystic fibrosis? Cystic fibrosis (CF) is one of the most common life threatening genetic diseases, affecting approximately 1 out of 3,300 people. The severity of CF varies, with some children showing symptoms at birth, and others not diagnosed until they are teenagers or adults. In people with CF, a defective gene causes the body to produce an abnormally thick, sticky mucus that clogs the lungs and leads to life threatening lung infections. These thick secretions also obstruct the pancreas, preventing digestive enzymes from reaching the intestines to help break down and absorb food. Cystic fibrosis does not affect intelligence. Most males with the condition are infertile. Is there treatment for cystic fibrosis? CF treatment has improved dramatically in the past four decades, although there is no cure. Treatment includes antibiotics, dietary enzyme supplements and physical therapy to help clear the lungs. A lung transplant may be an option for some patients. In the past, most patients with CF did not reach adulthood. Now most survive into their 30s, with the average life expectancy being about 37 years. How is cystic fibrosis inherited? Cystic fibrosis is inherited in an autosomal recessive manner. Our genes come in pairs, with one copy inherited from each parent. Some genes have mutations in them, and do not function properly. A person with one non-functional copy of the gene is a carrier. Carriers for CF have no symptoms, but can pass the non-functioning gene on to their children. An individual must inherit two non-functioning CF genes – one from each parent – to have CF. If both parents are carriers there is a 1 in 4 (25 percent) chance that both will pass on the non-functioning gene, which would result in a pregnancy affected with cystic fibrosis. How do I know if I am a carrier of cystic fibrosis? Carrier testing is available through a simple blood test. There are over 1,000 mutations that have been found to cause CF. Carrier screening can be done for the most common of these, and will identify about 85 to 90 percent of carriers in the Caucasian population. Carrier testing is also available for other ethnic groups, but the detection rates and carrier frequencies vary. If no one in your family has CF, your chance of being a carrier depends upon your ancestry:

  • European Caucasians, Ashkenazi Jews – 1 in 29
  • Hispanic Americans – 1 in 46
  • African Americans – 1 in 61
  • Asian Americans – 1 in 90

If you have a family history of CF, your risk may be higher regardless of your ancestry. If my test result is normal, can I still be a carrier? Yes. If you have the test and no CF mutation is identified, your chance of being a CF carrier is reduced but not eliminated. Some people are carriers of a rare CF mutation that cannot be detected by routine screening. There is still a small chance that someone with a negative test result could be a carrier and have a child with CF. What does it mean if I am a carrier? If you are a carrier, there is no impact on your health. However, there is a chance that you could have a child with CF. Your partner should undergo carrier screening if this has not already been performed. If only one of you is found to be a carrier, the chance that you will have a child with CF is very low, although not completely eliminated. If you are both carriers, each pregnancy will have a 1 in 4, or 25 percent chance of being affected with cystic fibrosis. Is prenatal testing available? If both partners are carriers of cystic fibrosis, prenatal testing is available. Chorionic villus sampling (CVS) at 10 to 14 weeks or amniocentesis at 16 to 20 weeks can be performed to determine if the fetus has inherited two copies of the cystic fibrosis gene mutation. If you and your partner are both carriers and you are thinking of becoming pregnant, there are other options available. You can meet with a genetic counselor to discuss these issues. Is cystic fibrosis tested on the newborn screen? Yes. Before your baby leaves the hospital, his or her blood sample will be collected on a piece of filter paper with a simple heel stick. Your baby will be tested for several different conditions, including cystic fibrosis. For more information about cystic fibrosis, genetic counseling, or to arrange carrier or prenatal testing, please contact the Prenatal Diagnostic Center .

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01How Do I Take Alyftrek for Cystic Fibrosis?

Your health care provider will decide the correct dose of Alyftrek based on your age and weight. Alyftrek is a tablet that is taken by mouth. It should be swallowed whole with food that contains fat, such as eggs, nuts, meats, or dairy products, to help the body absorb the medicine properly. The treatment plan usually follows these steps after receiving the recommended liver evaluations and tests: For people aged 6 to <12 years (<40 kg): Take three tablets (vanzacaftor 4 mg/tezacaftor 20 mg/ deutivacaftor 50 mg) once daily with fat-containing food. For people aged 6 to <12 years (≥40 kg) or ≥12 years: Take two tablets (vanzacaftor 10 mg/tezacaftor 50 mg/deutivacaftor 125 mg) once daily with fat-containing food. Dose adjustments may be needed in people with liver problems. Alyftrek should be taken at the same time each day to maintain steady levels of the medicine in the body. Keep all appointments with your health care provider before and while taking Alyftrek. Your health care provider may monitor how well your liver is working.

Source: www.webmd.com ↗
02Are there any risks to the test?

There is no known risk to a sweat test. The electrode may cause a tingling or tickling sensation from the electric current, but this is not painful.

Source: medlineplus.gov ↗
03What you can do

You might want to take a friend or family member with you to the appointment to help you remember information. Before your appointment, make a list of: Symptoms and when they started. Include anything that makes symptoms worse or better. All medicines, vitamins, herbs and supplements that you or your child take. Include the doses. Family history, such as whether anyone in your family has cystic fibrosis. Treatment you or your child have had for CF, if any. Include what the treatment was and if it helped. Any other medical conditions and their treatments. Questions to ask your healthcare professional. Questions to ask may include: What is likely causing these symptoms? What kinds of tests are needed? What treatment do you recommend? I or my child have other health conditions. How will cystic fibrosis affect them? Are there any limits needed? Feel free to ask other questions during your appointment.

Source: www.mayoclinic.org ↗
04What is cystic fibrosis? A Mayo Clinic expert explains

Learn more from pulmonologist Sarah Chalmers, M.D. Cystic fibrosis (CF) is a condition passed down in families that causes damage to the lungs, digestive system and other organs in the body. CF affects the cells that make mucus, sweat and digestive juices. These fluids, also called secretions, are usually thin and slippery to protect the body's internal tubes and ducts and make them smooth pathways. But in people with CF, a changed gene causes the secretions to become sticky and thick. The secretions plug up pathways, especially in the lungs and pancreas. CF gets worse over time and needs daily care, but people with CF usually can attend school and work. They often have a better quality of life than people with CF had in past decades. Better screening and treatments mean that people with CF now may live into their mid- to late 50s or longer, and some are being diagnosed later in life.

Source: www.mayoclinic.org ↗
05What Is Cystic Fibrosis?

Cystic fibrosis (CF) is a genetic disorder, which means you get it from your parents at birth. It affects your lungs, pancreas, and other organs. CF changes the way chloride (salt) moves through the cells of your body. This causes the mucus (which should be thin and slippery) in various organs to become thick and sticky. Over time, this thick mucus builds up inside your airways, making it hard to breathe. The mucus traps germs and leads to infections and inflammation. It can also cause severe, long-term damage to the lungs and lead to respiratory failure (inability to breathe normally) and death. In the pancreas, the thick mucus caused by CF prevents the release of digestive enzymes when you eat. This leads to malnutrition and poor growth. CF can also cause liver disease, reproductive problems, and cystic fibrosis-related diabetes (CFRD). More than 40,000 people in the U.S. live with CF. Doctors diagnose about 1,000 new cases each year. Today, more than half of the CF population is aged 18 or older, and new treatments have expanded the life expectancy by decades.

Source: www.webmd.com ↗
Research context

Read sources and limitations before applying a claim.

Research and Statistics: Who Has Cystic Fibrosis?

About 40,000 people are living with cystic fibrosis in the United States, and there are approximately 105,000 people with CF worldwide. (3) More than 75 percent of people with the disease are diagnosed by age 2, and more than half of all people living with cystic fibrosis are 18 or older. CF occurs predominantly in white populations, at a rate of 1 in 2,500 births. Between 2 and 5 percent of white people are carriers of the CFTR gene variant but have no overt clinical signs of disease. The disease is less common among African Americans, occurring at the much lower frequency of approximately 1 out of 17,000 births. (15) CF gene variants are most prevalent in persons of northern and central European ancestries or of Ashkenazi Jewish descent. They are rarely found in Native Americans, Asians, or native Africans. (16) CF is equally common among men and women, but women patients fare significantly worse than male patients with the disease. The median survival age for female CF patients is about three years younger than it is for men, but the reasons for the poorer survival rates among women are not completely understood. (17)

Source: everydayhealth.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →